|
|
Volumn 94, Issue 8, 2002, Pages 550-552
|
|
On the eve of protein destruction: Ubiquitin research begins to pay off
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BORTEZOMIB;
CARBOPLATIN;
ETOPOSIDE;
LIGASE;
LIGASE INHIBITOR;
PACLITAXEL;
PROTEASOME INHIBITOR;
PROTEIN MDM2;
PROTEIN P53;
UBIQUITIN;
UBIQUITIN PROTEIN LIGASE;
ARTICLE;
CANCER RESEARCH;
CHRONIC MYELOID LEUKEMIA;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG MECHANISM;
DRUG SCREENING;
DRUG SYNTHESIS;
HUMAN;
MALIGNANT TRANSFORMATION;
MELANOMA;
MULTIPLE MYELOMA;
OVARY CARCINOMA;
PAIN;
PRIORITY JOURNAL;
PROTEIN DEGRADATION;
SOLID TUMOR;
|
|
EID: 0037123343
PISSN: 00278874
EISSN: None
Source Type: Journal
DOI: 10.1093/jnci/94.8.550 Document Type: Article |
|
Times cited : (4)
|
|
References (0)
|